A. Hela

Serum IGFBP-3 is a more effective predictor than IGF-1 and IGF-2 for the development of hepatocellular carcinoma in patients with chronic HCV infection.

E. Aleem, A. Elshayeb, A. Gowily, 2012, Oncology letters.